Of note, this CDK4/6 inhibitor was less effective when BC cells were co-cultured with CAFs, in accordance with previous findings indicating that fibroblasts may alter tumor responses to chemotherapeutics [52]. This evidence concerns the gene CDK4 and breast cancer.